ResMed faces an uncertain future as GLP-1 weight loss drugs threaten to reduce demand for sleep apnea devices, creating a complex investment dilemma for shareholders of the CPAP machine leader.

Much of David Gardner's advice bucks traditional investing wisdom. He doesn't recommend following the traditional wisdom to ...

Neru Health, an artificial intelligence (AI)-powered care automation platform for sleep clinics and durable medical equipment (DME) providers, has quickly ramped up, helping thousands of patients with ...

Mayo Clinic doctors tap into AI technology to detect and treat women with sleep apnea, a disorder that's often misdiagnosed ...

On Sunday, NASA's Escapade, a collaborative effort among the space agency, UC Berkeley and Jeff Bezos' Blue Origin, will ...